CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 108 enrolled
Drug / intervention
Korean Red Ginseng Extract Powder 120 mg/tablet +2 moredietary
Likely dose
Korean Red Ginseng Extract Powder 120 mg/tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06236243
NCT06236243N/ACompleted
CompareCT.gov

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Effect of G1899 (Korean Red Ginseng Extract Powder) on Blood Flow in Healthy Adults

Korea Ginseng Corporation·interventional·Posted Feb 1, 2024·Updated Nov 27, 2024

In Brief

A clinical study evaluating Korean Red Ginseng Extract Powder 120 mg/tablet, Korean Red Ginseng Extract Powder 500 mg/tablet, and 1 other intervention for Cardiovascular Diseases and 3 related conditions. Completed, enrolled 108 participants across 1 site.

Detailed Summary

The objectives of this clinical trial are to 1) determine the effect of the TP compared to placebo on blood flow and platelet aggregation, 2) to determine the effect of the TP on cardiovascular health compared to a placebo and 3) to assess the safety and tolerability of the TP in healthy adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Blood Pressure Disorders, Vasodilation, Platelet Aggregation
CountriesUnited States
CollaboratorsNutrasource Pharmaceutical and Nutraceutical Services, Inc.

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 1, 2024
Enrollment StartJan 31, 2024
Primary CompletionSep 25, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.4 years ago

Interventions

Korean Red Ginseng Extract Powder 120 mg/tabletdietary

Participants will take 2 tablets 2 times daily (preferably after breakfast and after dinner) for 12 weeks.

Korean Red Ginseng Extract Powder 500 mg/tabletdietary

Participants will take 2 tablets 2 times daily (preferably after breakfast and after dinner) for 12 weeks.

Placebodietary

Participants will take 2 tablets 2 times daily (preferably after breakfast and after dinner) for 12 weeks.